Emerging Biopharma

China export industry and global supply chain Cargo airplane flying over logistic containers
Biotech

AirNexis swoops in with $200M series A for COPD asset

AirNexis has inked a deal potentially worth almost $1 billion with a China biopharma, securing rights to a clinical-stage COPD asset.
Gabrielle Masson Jan 9, 2026 11:01am
eyeball eye disease eyelash eyes

Ollin eyes phase 3 after topping Vabysmo in early-stage trial

Jan 8, 2026 3:20pm
Ron Park CEO

Addition Tx does the math and emerges from stealth with $100M

Dec 17, 2025 7:45am
yarrow

Yarrow blooms with $1.37B autoimmune thyroid disease deal

Dec 16, 2025 11:00am
graphic image of different colored hands shaking

Crescent inks $80M Kelun deal, adding ADC to mix with bispecific

Dec 4, 2025 9:50am
Winding 3D road with dollar bills

Protego tucks $130M series B into its fold

Dec 1, 2025 6:00am
More News

Federal commission warns that US is losing innovative edge

Nov 25, 2025 3:47pm

Versant's Dayra dawns with $50M Biogen pact

Nov 24, 2025 10:28am

Lilly picks Philadelphia for newest Gateway Labs site

Nov 19, 2025 6:45am

Bayer opens Beijing incubator, names initial occupants

Nov 17, 2025 10:18am